Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Amortization of Deferred Charges: 2020-2021

Historic Amortization of Deferred Charges for Revolution Medicines (RVMD) over the last 2 years, with Dec 2021 value amounting to $3.2 million.

  • Revolution Medicines' Amortization of Deferred Charges was N/A to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2021, which is 10.96% up from last year.
  • Revolution Medicines' Amortization of Deferred Charges amounted to $3.2 million in FY2021, which was up 10.96% from $2.9 million recorded in FY2020.
  • In the past 5 years, Revolution Medicines' Amortization of Deferred Charges ranged from a high of $3.2 million in FY2021 and a low of $2.9 million during FY2020.
  • Its 2-year average for Amortization of Deferred Charges is $3.0 million, with a median of $3.0 million in 2020.
  • Data for Revolution Medicines' Amortization of Deferred Charges shows a peak YoY increased of 10.96% (in 2021) over the last 5 years.
  • Revolution Medicines' Amortization of Deferred Charges (Yearly) stood at $2.9 million in 2020, then grew by 10.96% to $3.2 million in 2021.